Wireless Opportunities in Healthcare
The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies
| Publication Date | January 2007 |
|---|---|
| Publisher | Kalorama Information |
| Product Type | Report |
| Pages | 286 |
| ISBN Number | not applicable |
| Product Code | KAL00037 |
Summary
This completely updated edition of this comprehensive and indispensable report covers the breadth of traditional IVD testing. The report contains complete market statistics and analysis for all areas of IVD, including:
- Point-of-Care
- Clinical Chemistry
- Immunoassays
- Molecular Assays
- Hematology
- Coagulation
- Microbiology and Virology
- Blood Banking
- Histology and Cytology
Market size, growth, share, and geographic distribution, as well as trends in technology development, regulatory and reimbursement issues, clinical care, and business environments are discussed. Projections are made through 2010.
This new 1,000-page edition greatly expands coverage of the field and tracks the most important developments. Expanded or added in this edition are sections on:
- the movement toward POC and decentralization in lab medicine
- miniaturization and molecularization of devices
- geo-economic and demographic influences on markets
- non-invasive sampling
- greatly expanded market data on PGx and SNP testing
- revamped segmentation for clinical chemistry to include workstations and immunoanalyzers
- more information about more immunoassays
- the renewed interest in microbiology/virology based on resistance and the re-emergence of serious hospital- and community-based organisms
- world blood banking developments
- expanded sections on histology/cytology developments including emerging areas such as tissue microarrays, circulating tumor cells, and genomics-fueled innovation.
In addition, there are now profiles of more than established and emerging players in IVD with profiles of more than 421 companies, from the top tier to emerging and niche competitors to watch.
Content
- Chapter One: Executive Summary
- 1.1 Healthcare Industry
- 1.2 Wireless Industry
- 1.3 Wireless in Healthcare
- 1.4 Definition and Scope of Study
- 1.5 Application of Wireless Technologies in Healthcare
- 1.5.1 Emerging Applications
- 1.6 Key Wireless Technologies
- 1.7 Implementing Wireless Technologies in Healthcare
- 1.8 Market Overview
- 1.8.1 Market for Wireless Technologies in Healthcare
- 1.8.2 Competitive Landscape
- 1.9 Consumer Analysis
- 1.10 Regulatory Environment
- 1.11 Conclusions and Future Outlook
- Chapter Two: Overview
- 2.1 Healthcare Industry
- 2.1.1 Worldwide Healthcare Market
- 2.1.1.1 Information Technology (IT) Market in Healthcare
- 2.1.2 Trends
- 2.1.3 Challenges
- 2.2 Wireless Industry
- 2.2.1 Worldwide Wireless Market
- 2.2.2 Trends
- 2.2.3 Challenges
- 2.3 Wireless in Healthcare
- 2.3.1 US - The Best Market for Wireless Technologies in Healthcare
- 2.3.2 Trends
- 2.3.3 Challenges
- 2.4 Definition and Scope of Study
- Chapter Three: Opportunities for Wireless Applications in Healthcare
- 3.1 Introduction
- 3.1.1 Key Benefits
- 3.2 Healthcare Industry Segmentation for Wireless Applications
- 3.2.1 Healthcare Service Providers
- 3.2.1.1 Applications of Wireless Technologies for Healthcare Service Providers Segment
- 3.2.2 Pharmaceuticals
- 3.2.2.1 Application of Wireless Technologies for the Pharmaceuticals Segment
- 3.2.3 Health Plan Providers
- 3.2.3.1 Applications of Wireless Technologies for Health Plan Providers Segment
- 3.3 Key Applications
- 3.3.1 Remote Patient Monitoring
- 3.3.1.1 Market Overview
- 3.3.2 Clinical Drug Trials
- 3.3.2.1 Market Overview
- 3.3.3 E-Prescription
- 3.3.3.1 Market Overview
- 3.3.4 Patient/Asset Tracking
- 3.3.4.1 Market Overview
- 3.3.5 Pharmaceutical Sales Force
- 3.3.5.1 Market Overview
- Chapter Four: Key Wireless Technologies
- 4.1 Data Transmission Sessions
- 4.2 Wireless Operating Systems, Languages, and Protocols
- 4.3 Wireless Networking Technologies
- 4.3.1 Wireless Personal Area Network - Bluetooth
- 4.3.1.1 Market Overview
- 4.3.1.2 Benefits of Bluetooth in Healthcare
- 4.3.1.3 Applications of Bluetooth in Healthcare
- 4.3.1.4 Issues with Bluetooth Adoption in Healthcare
- 4.3.2 Wireless Personal Area Network - RFID
- 4.3.2.1 Market Overview
- 4.3.2.2 Benefits of RFID in Healthcare
- 4.3.2.3 Applications of RFID in Healthcare
- 4.3.2.4 Issues with RFID Adoption in Healthcare
- 4.3.3 Wireless Personal Area Network - Zigbee
- 4.3.3.1 Market Overview
- 4.3.3.2 Benefits of Zigbee in Healthcare
- 4.3.3.3 Applications of Zigbee in Healthcare
- 4.3.3.4 Issues with Zigbee Adoption in Healthcare
- 4.3.4 Wireless Personal Area Network - UWB
- 4.3.4.1 Market Overview
- 4.3.4.2 Benefits of UWB in Healthcare
- 4.3.4.3 Applications of UWB in Healthcare
- 4.3.5 Wireless Local Area Network (WLAN)
- 4.3.5.1 Market Overview
- 4.3.5.2 Benefits of WLAN in Healthcare
- 4.3.5.3 Applications of WLAN in Healthcare
- 4.3.5.4 Issues with WLAN Adoption in Healthcare
- 4.3.6 Wireless Metropolitan Area Network (WMAN)
- 4.3.6.1 Market Overview
- 4.3.6.2 Benefits of WMAN in Healthcare
- 4.3.6.3 Applications of WMAN in Healthcare
- 4.3.6.4 Issues with WMAN Adoption in Healthcare
- 4.3.7 Wireless Wide Area Network (WWAN)
- 4.3.7.1 Market Overview
- 4.3.7.2 Benefits of WWAN in Healthcare
- 4.3.7.3 Applications of WWAN in Healthcare
- 4.3.7.4 Issues with WWAN Adoption in Healthcare
- Chapter Five: Implementing Wireless Technologies in Healthcare
- 5.1 Wireless Infrastructure for Healthcare
- 5.2 Planning for Wireless Infrastructure Deployment
- 5.3 Initiation and Execution of a Wireless Deployment Project
- 5.4 Cost of Implementation of Infrastructure
- 5.4.1 Cases of Wireless Implementation Costs
- 5.4.2 Return-on-Investment Period
- Chapter Six: Market Overview of Wireless Technologies in Healthcare
- 6.1 Market Definition
- 6.2 Market Size
- 6.2.1 The US Wireless Market in Healthcare
- 6.2.1.1 Technology-wise Market Break-up
- 6.2.2 WPAN - Bluetooth Market in Healthcare
- 6.2.3 WPAN - RFID Market in Healthcare
- 6.2.4 WPAN - Zigbee Market in Healthcare
- 6.2.5 WPAN - UWB Market in Healthcare
- 6.2.6 WLAN Market in Healthcare
- 6.2.7 WMAN Market in Healthcare
- 6.2.8 WWAN Market in Healthcare
- 6.3 Technology Adoption
- 6.4 Competitive Landscape
- 6.4.1 Segmentation of Players
- 6.4.1.1 Network Infrastructure Providers
- 6.4.1.2 Software Providers
- 6.4.1.3 Medical Device Manufacturers
- 6.4.2 Market Shares
- 6.4.3 Distribution Channel
- 6.5 Drivers and Inhibitors
- 6.5.1 Growth Drivers
- 6.5.2 Growth Inhibitors
- 6.6 Emerging Trends
- 6.6.1 Emerging Applications
- 6.6.1.1 Nanobots
- 6.6.1.2 Implantable Medical Devices
- Chapter Seven: Demand Side Analysis
- 7.1 Consumer Statistics
- 7.1.1 Hospitals
- 7.1.1.1 Number of Hospitals
- 7.1.1.2 Technology Adoption in Hospitals
- 7.1.1.3 The Most Wireless Hospitals
- 7.1.2 Physicians
- 7.1.2.1 Number of Physicians
- 7.1.2.2 Technology Adoption by Physicians
- 7.1.3 Nursing Homes
- 7.1.3.1 Technology Adoption by Nursing Homes
- 7.1.4 Pharmacies
- 7.1.4.1 Technology Adoption by Pharmacies
- 7.1.5 Medical and Diagnostic Laboratories
- 7.1.5.1 Technology Adoption by Laboratories
- 7.1.5 Life Insurance Carriers
- 7.1.5.1 Technology Adoption by Life/Health Insurance Carriers
- 7.1.6 Demography
- 7.2 Consumer Preferences and Challenges
- 7.2.1 IT Preferences
- 7.2.2 Technology Adoption Preferences
- 7.2.3 IT Budget of Healthcare Facilities
- 7.2.4 Barriers in Implementing IT
- Chapter Eight: Case Studies
- 8.1 George Washington University Hospital - WLAN Implementation
- 8.1.1 Requirement for Implementation of Wireless Technologies
- 8.1.2 Expected Benefits
- 8.1.3 Planning and Implementation
- 8.1.4 Cost of Implementation
- 8.1.5 Challenges in Implementation
- 8.2 Memorial Medical Center - WLAN Implementation
- 8.2.1 Requirement for Implementation of Wireless Technologies
- 8.2.2 Planning and Implementation
- 8.2.3 Challenges in Implementation
- 8.3 Good Shepherd Hospital - RFID Implementation
- 8.3.1 Requirement for RFID Technology Adoption
- 8.3.2 Benefits
- 8.4 Smith & Nephew - Sales Force Automation
- 8.4.1 Planning and Implementation
- 8.4.2 Benefits
- 8.5 Achieve Healthcare Technologies - e-Prescription
- 8.5.1 Requirement for e-Prescription
- 8.5.2 Benefits
- 8.5.3 Challenges in Implementation
- 8.6 Bayer Healthcare - e-Drug Trials
- 8.6.1 Requirement for e-Drug Trials
- 8.6.2 Benefits
- 8.6.3 Planning and Implementation
- 8.7 Island Health Care - Tele-homecare
- 8.7.1 Requirement for Tele-homecare
- 8.7.2 Benefits
- 8.8 Wireless Technologies for Patient Recovery - Remote Patient Monitoring
- 8.8.1 Requirement for Remote Monitoring
- 8.8.2 Telemonitoring Solution
- 8.8.3 Results
- Chapter Nine: Regulatory Environment
- 9.1 Need for Regulation
- 9.2 Defining the Network Security Policy for Health Organizations
- 9.2.1 Planning the Policy
- 9.2.1.1 E-mail Access
- 9.2.1.2 Content Filtering
- 9.2.1.3 Virtual Private Networks
- 9.2.2 Implementing the Policy
- 9.2.3 Using the Policy
- 9.3 Regulatory Bodies and Societies
- 9.3.1 United States Department of Health and Human Services
- 9.3.1.1 Health Insurance Portability and Accountability Act (HIPAA)
- 9.3.2 Health Level Seven
- 9.3.3 Federal Communication Commission
- 9.3.3.1 Wireless Telecommunications Bureau
- 9.3.4 Healthcare Information and Management Systems Society
- 9.3.5 Health Industry Business Communications Council
- 9.4 Industry Initiatives
- Chapter Ten: Conclusions
- 0.1 First Conclusion
- 10.2 Second Conclusion
- 10.3 Third Conclusion
- 10.4 Fourth Conclusion
- 10.5 Fifth Conclusion
- 10.6 Sixth Conclusion
- 10.7 Seventh Conclusion
- Chapter Eleven: Company Profiles
- 11.1 Network Infrastructure Providers
- 11.1.1 Cisco Systems, Inc.
- 11.1.1.1 Company Overview
- 11.1.1.2 Geographical Presence
- 11.1.1.3 Performance Review
- 11.1.1.4 Product Portfolio
- 11.1.1.5 Company Strategy
- 11.1.2 Extreme Networks, Inc.
- 11.1.2.1 Company Overview
- 11.1.2.2 Geographical Presence
- 11.1.2.3 Performance Review
- 11.1.2.4 Product Portfolio
- 11.1.2.5 Company Strategy
- 11.1.3 Nortel Networks Corporation
- 11.1.3.1 Company Overview
- 11.1.3.2 Geographical Presence
- 11.1.3.3 Performance Review
- 11.1.3.4 Product Portfolio
- 11.1.3.5 Company Strategy
- 11.1.4 Symbol Technologies, Inc.
- 11.1.4.1 Company Overview
- 11.1.4.2 Geographical Presence
- 11.1.4.3 Performance Review
- 11.1.4.4 Product Portfolio
- 11.1.4.5 Company Strategy
- 11.1.5 Terabeam, Inc.
- 11.1.5.1 Company Overview
- 11.1.5.2 Geographical Presence
- 11.1.5.3 Performance Review
- 11.1.5.4 Product Portfolio
- 11.1.5.5 Company Strategy
- 11.2 Software Providers
- 11.2.1 Cerner Corporation
- 11.2.1.1 Company Overview
- 11.2.1.2 Geographical Presence
- 11.2.1.3 Performance Review
- 11.2.1.4 Product Portfolio
- 11.2.1.5 Company Strategy
- 11.2.2 Eclipsys Corporation
- 11.2.2.1 Company Overview
- 11.2.2.2 Geographical Presence
- 11.2.2.3 Performance Review
- 11.2.2.4 Product Portfolio
- 11.2.2.5 Company Strategy
- 11.2.3 McKesson Corporation
- 11.2.3.1 Company Overview
- 11.2.3.2 Geographical Presence
- 11.2.3.3 Performance Review
- 11.2.3.4 Product Portfolio
- 11.2.3.5 Company Strategy
- 11.2.4 QuadraMed Corporation
- 11.2.4.1 Company Overview
- 11.2.4.2 Geographical Presence
- 11.2.4.3 Performance Review
- 11.2.4.4 Product Portfolio
- 11.2.4.5 Company Strategy
- 11.2.5 Sybase, Inc.
- 11.2.5.1 Company Overview
- 11.2.5.2 Geographical Presence
- 11.2.5.3 Performance Review
- 11.2.5.4 Product Portfolio
- 11.2.5.5 Company Strategy
- 11.3 Medical Device Manufacturers
- 11.3.1 Cardinal Health, Inc.
- 11.3.1.1 Company Overview
- 11.3.1.2 Geographical Presence
- 11.3.1.3 Performance Review
- 11.3.1.4 Product Portfolio
- 11.3.1.5 Company Strategy
- 11.3.2 Datascope Corporation
- 11.3.2.1 Company Overview
- 11.3.2.2 Geographical Presence
- 11.3.2.3 Performance Review
- 11.3.2.4 Product Portfolio
- 11.3.2.5 Company Strategy
- 11.3.3 GE Healthcare
- 11.3.3.1 Company Overview
- 11.3.3.2 Geographical Presence
- 11.3.3.3 Performance Review
- 11.3.3.4 Product Portfolio
- 11.3.3.5 Company Strategy
- 11.3.4 Philips Medical Systems
- 11.3.4.1 Company Overview
- 11.3.4.2 Geographical Presence
- 11.3.4.3 Performance Review
- 11.3.4.4 Product Portfolio
- 11.3.4.5 Company Strategy
- 11.3.5 Siemens Medical Solutions
- 11.3.5.1 Company Overview
- 11.3.5.2 Geographical Presence
- 11.3.5.3 Performance Review
- 11.3.5.4 Product Portfolio
- 11.3.5.5 Company Strategy
About this Product
Delivery Details
PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)
PRINT/CD-ROM:Despatched within 2 to 4 working days.
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















